In case you would like to receive sms-reminders for the event you have registered, please update your communication preferences here. Account activated - pending validation. In the meantime, you can enjoy the public content on our website. Event Account activated - pending validation.

View Basket. Filter Tags values when filtered by all Tags: All Therapy Areas. Events registration success message: Registration successfull. Events registration failure message: Registration failure. Events un-registration success message: Un-Registration successfull.

Events un-registration failure message: Un-Registration failure. Text Area Blank copy in Email Template: Not Provided.

You are leaving GSK Pro to visit a separate website not associated with GSK Pro, a portal for US Healthcare Professionals. There are website links to third-party sites on GSK Pro. GSK is not responsible for content on third-party websites.

Registration and enrollment is required to request offers. Get Started. Prescription drug samples and savings offers may be provided, in accordance with State laws, PDMA guidelines, medical specialty, and at the discretion of GSK.

Offers are not guaranteed to be available and can be discontinued at any time. For example, sample use has increased among insulin users in recent years, and is associated with higher per-prescription costs over nonusers of samples [ 52 ]. Samples may have increased prescription rates for expensive insulin delivery systems that provide little or no benefit in patient outcomes.

Samples can lead to discontinuity in treatment after patients run out of samples of a drug they cannot afford. Receiving day samples of generic drugs, on the other hand, increases adherence [ 53 ]. Adherence to generic drugs is higher than to branded drugs, probably because patients can afford them [ 54 ].

A pilot project by a managed care organization found that physicians prescribe generic drugs more when the sample closet is filled with generics [ 55 ]. Many practices fail to store sample drugs safely.

Some hospitals have allowed pharmaceutical representatives to stock and monitor sample closets [ 56 ]. In the U. There are environmental concerns as well. Waste generated from drug samples is estimated to be metric tons per year [ 58 ].

Sampling is banned in many academic institutions, including the University of Michigan health system and Stanford University Medical School [ 59 ]. Some physician practices refuse samples as well [ 60 , 61 ]. However, physician dispensing of drug samples is still considered acceptable by the American Medical Association and the American Academy of Family Practitioners [ 62 ].

Additionally, the FDA temporarily loosened restrictions on sampling in response to the COVID pandemic [ 63 ]. Because many offices have reduced in-person interactions, including drug rep and patient visits, samples can now be shipped directly to patients. This new guidance makes it easier for pharmaceutical companies to distribute samples in spite of decades of evidence that samples cause harm.

With little guidance at the national level, the decision of whether or not to accept samples in private practice is largely left to individual physicians. Samples are not a charitable activity, but are instead a highly effective form of drug marketing.

Samples remain the largest marketing investment among most companies. Pharmaceutical companies would not invest so much in optimizing sampling distribution if they did not see a return on investment from these strategies. The sampling of branded drugs increases drug costs for everyone.

While some countries, states and other jurisdictions have laws and regulations that address gifts to physicians, drug sample provision is always excluded.

This needs to change: samples are gifts. In the meantime, individual prescribers have the power to change this practice by refusing samples.

Laws that address gifts to prescribers should always include samples as gifts. Brown SR. Physicians should refuse pharmaceutical industry gifts. Am Fam Physician.

PubMed Google Scholar. Dewatripont M, Goldman M. Free drug samples and the opioid crisis. N Engl J Med. Article PubMed Google Scholar. Katz KA, Reid EE, Chren MM. Drug samples in dermatology: out of the closet, into the dustbin. JAMA Dermatol. Article PubMed PubMed Central Google Scholar. Tran LL. Drug samples: why not?

Virtual Mentor VM. Wendling P. Physicians are split on the ethics of free drug samples. Cardiology News. Published March 1, Accessed 6 Jan Dong X, Li M, Xie Y. Understanding Sample Usage and Sampling as a Promotion Tool: State of Industry Practice and Current Research.

In: Ding M, Eliashberg J, Stremersch S, editors. Innovation and Marketing in the Pharmaceutical Industry: Emerging Practices, Research, and Policies. International Series in Quantitative Marketing.

New York: Springer; Chapter Google Scholar. Joseph K, Mantrala M. Mark Lett. Article Google Scholar. Schwartz LM, Woloshin S. Medical Marketing in the United States, — Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician—industry relationships.

Article CAS PubMed Google Scholar. Lessard A, Lussier MT, Diallo FB, et al. Drug samples in family medicine teaching units: a cross-sectional descriptive study. Can Fam Physician. PubMed PubMed Central Google Scholar. Hurley MP, Stafford RS, Lane AT. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.

Article CAS PubMed PubMed Central Google Scholar. Groves KEM, Sketris I, Tett SR. Prescription drug samples — does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther. Federal Trade Commission.

A Review of Food Marketing to Children and Adolescents; Li H, Jain S, Kannan PK. Optimal design of free samples for digital products and services. J Mark Res. Scott CA. The effects of trial and incentives on repeat purchase behavior. Shiv B, Nowlis SM. The effect of distractions while tasting a food sample: the interplay of informational and affective components in subsequent choice.

J Consum Res. Gedenk K, Neslin S. The role of retail promotion in determining future brand loyalty: its effect on purchase event feedback. Published Online. Chandukala SR, Dotson JP, Liu Q. An assessment of when, where and under what conditions in-store sampling is most effective. J Retail.

Bawa K, Shoemaker R. The effects of free sample promotions on incremental brand sales. Mark Sci. Gönül FF, Carter F, Petrova E, Srinivasan K. J Mark. Brown BP, Bellenger DN, Johnston WJ. The Implications of business-to-business and consumer market differences for B2B branding strategy.

J Bus Mark Manag. Gaedeke RM, Tootelian DH, Sanders EE. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.

Health Mark Q. Montoya R, Netzer O, Jedidi K. Dynamic allocation of pharmaceutical detailing and sampling for long-term profitability. Venkataraman S, Stremersch S. Manag Sci. Bala R, Bhardwaj P, Chen Y. Offering pharmaceutical samples: the role of physician learning and patient payment ability.

Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. Neslin S. ROI analysis of pharmaceutical promotion RAPP : An independent study. Accessed 22 May J Gen Intern Med. Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF.

The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. CAS PubMed Google Scholar. Westfall JM, McCabe J, Nicholas RA.

Personal use of drug samples by physicians and office staff. Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. Weinstein D. Samples no longer hold sway in pharma marketing mix: study.

Published February 21, Adair R. Hidden costs of free samples. AMA J Ethics. Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.

Med Care. Gellad WF, Grenard JL, Marcum ZA. You will receive an order confirmation shortly after your order is received, and tracking information once it has been shipped. If you are a healthcare provider, use this form to request samples for your patient or practice. If you represent a home medical supplier or durable medical equipment supplier, use this form to request samples for a patient.

We'll have your form in just a moment. Skip to content. Products Nutrition, ingredients, specifications, detail sheets, and ordering information.

Resources Usage and storage guidelines, supporting tools, and documents.

Explore the variety of free samples that Universal Medical makes available to qualified healthcare and laboratory organizations Free Samples at AliMed Branded drug samples are one of the most important promotional tools that pharmaceutical manufactures employ

Medical product samples - Bayer® is committed to providing resources and free samples from the available products to registered healthcare professionals Explore the variety of free samples that Universal Medical makes available to qualified healthcare and laboratory organizations Free Samples at AliMed Branded drug samples are one of the most important promotional tools that pharmaceutical manufactures employ

Medical Education Register for medical education opportunities. Mobile Menu link. Clinicians Logo. Search Icon. Samples Kate Farms is happy to provide healthcare providers access to free samples of our medical formulas for their patients to trial for taste or tolerance.

For healthcare providers If you are a healthcare provider, use this form to request samples for your patient or practice. For home medical suppliers If you represent a home medical supplier or durable medical equipment supplier, use this form to request samples for a patient.

Drug pricing legislation moving through Congress could force medical device manufacturers to report the value of product samples given to certain healthcare providers. This could include free samples a doctor uses when educating patients on device use. AdvaMed and the Medical Device Manufacturers Association, along with state-based affiliates, including BioUtah, are urging policymakers to exclude medical device samples from such requirements.

In April, the House Ways and Means Committee passed the Prescription Drug STAR Act H. The measure included the Sunshine for Samples Act H. Both drug and device samples would be covered. Under the samples legislation, each year, manufacturers would be required to report to CMS the aggregate monetary value and quantity of drug and device samples provided to covered recipients — physicians or their immediate family members and teaching hospitals.

Beginning in , such data would be posted by CMS to the Open Payments Database, in addition to other types of payments already required by law. Some hospitals have allowed pharmaceutical representatives to stock and monitor sample closets [ 56 ].

In the U. There are environmental concerns as well. Waste generated from drug samples is estimated to be metric tons per year [ 58 ]. Sampling is banned in many academic institutions, including the University of Michigan health system and Stanford University Medical School [ 59 ].

Some physician practices refuse samples as well [ 60 , 61 ]. However, physician dispensing of drug samples is still considered acceptable by the American Medical Association and the American Academy of Family Practitioners [ 62 ].

Additionally, the FDA temporarily loosened restrictions on sampling in response to the COVID pandemic [ 63 ]. Because many offices have reduced in-person interactions, including drug rep and patient visits, samples can now be shipped directly to patients.

This new guidance makes it easier for pharmaceutical companies to distribute samples in spite of decades of evidence that samples cause harm. With little guidance at the national level, the decision of whether or not to accept samples in private practice is largely left to individual physicians.

Samples are not a charitable activity, but are instead a highly effective form of drug marketing. Samples remain the largest marketing investment among most companies. Pharmaceutical companies would not invest so much in optimizing sampling distribution if they did not see a return on investment from these strategies.

The sampling of branded drugs increases drug costs for everyone. While some countries, states and other jurisdictions have laws and regulations that address gifts to physicians, drug sample provision is always excluded.

This needs to change: samples are gifts. In the meantime, individual prescribers have the power to change this practice by refusing samples. Laws that address gifts to prescribers should always include samples as gifts.

Brown SR. Physicians should refuse pharmaceutical industry gifts. Am Fam Physician. PubMed Google Scholar.

Dewatripont M, Goldman M. Free drug samples and the opioid crisis. N Engl J Med. Article PubMed Google Scholar. Katz KA, Reid EE, Chren MM. Drug samples in dermatology: out of the closet, into the dustbin. JAMA Dermatol. Article PubMed PubMed Central Google Scholar.

Tran LL. Drug samples: why not? Virtual Mentor VM. Wendling P. Physicians are split on the ethics of free drug samples. Cardiology News. Published March 1, Accessed 6 Jan Dong X, Li M, Xie Y. Understanding Sample Usage and Sampling as a Promotion Tool: State of Industry Practice and Current Research.

In: Ding M, Eliashberg J, Stremersch S, editors. Innovation and Marketing in the Pharmaceutical Industry: Emerging Practices, Research, and Policies.

International Series in Quantitative Marketing. New York: Springer; Chapter Google Scholar. Joseph K, Mantrala M. Mark Lett. Article Google Scholar. Schwartz LM, Woloshin S. Medical Marketing in the United States, — Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D.

A national survey of physician—industry relationships. Article CAS PubMed Google Scholar. Lessard A, Lussier MT, Diallo FB, et al. Drug samples in family medicine teaching units: a cross-sectional descriptive study.

Can Fam Physician. PubMed PubMed Central Google Scholar. Hurley MP, Stafford RS, Lane AT. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea. Article CAS PubMed PubMed Central Google Scholar. Groves KEM, Sketris I, Tett SR.

Prescription drug samples — does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther. Federal Trade Commission. A Review of Food Marketing to Children and Adolescents; Li H, Jain S, Kannan PK. Optimal design of free samples for digital products and services.

J Mark Res. Scott CA. The effects of trial and incentives on repeat purchase behavior. Shiv B, Nowlis SM. The effect of distractions while tasting a food sample: the interplay of informational and affective components in subsequent choice.

J Consum Res. Gedenk K, Neslin S. The role of retail promotion in determining future brand loyalty: its effect on purchase event feedback. Published Online.

Chandukala SR, Dotson JP, Liu Q. An assessment of when, where and under what conditions in-store sampling is most effective. J Retail. Bawa K, Shoemaker R. The effects of free sample promotions on incremental brand sales. Mark Sci. Gönül FF, Carter F, Petrova E, Srinivasan K.

J Mark. Brown BP, Bellenger DN, Johnston WJ. The Implications of business-to-business and consumer market differences for B2B branding strategy.

J Bus Mark Manag. Gaedeke RM, Tootelian DH, Sanders EE. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives. Health Mark Q. Montoya R, Netzer O, Jedidi K. Dynamic allocation of pharmaceutical detailing and sampling for long-term profitability.

Venkataraman S, Stremersch S. Manag Sci. Bala R, Bhardwaj P, Chen Y. Offering pharmaceutical samples: the role of physician learning and patient payment ability. Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors.

PLoS Med. Neslin S. ROI analysis of pharmaceutical promotion RAPP : An independent study. Accessed 22 May J Gen Intern Med.

Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices.

J Fam Pract. CAS PubMed Google Scholar. Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff.

Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. Weinstein D. Samples no longer hold sway in pharma marketing mix: study.

Published February 21, Adair R. Hidden costs of free samples. AMA J Ethics. Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs.

Med Care. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.

Am J Geriatr Pharmacother. Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis.

Am J Public Health. Stevens D, Sharma K, Kesten S. Insurance status and patient behavior with asthma medications.

Video